SLS — SELLAS Life Sciences Group, Inc.

SLSSELLAS Life Sciences Group, Inc.

NAS · US · Healthcare · Biotechnology · sellaslifesciences.com

9.045USD-2.06%Mkt Cap: 1.71B USDP/E: —Last update: 2026-06-01

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidat…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap1.71B USD

Enterprise Value1.63B USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-26.86M USD

Revenue/Share—

Last Price9.045 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees13

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS81642T2096

Valuation

P/E (Trailing)—

P/E (Forward)-62.07

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B20.11

EPS (TTM)-0.23

EPS (Forward)-0.15

52W Range

1.39094% of range9.510

52W High9.510 USD

52W Low1.390 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-37.90%

ROA-34.29%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-28.39M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-1.03%

Net Debt-106.23M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.01

Current Ratio17.22

Quick Ratio16.59

Book Value/Sh0.4630 USD

Cash/Share0.5760 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateNov 8, 2019

Splits

Last Split1:50

Split DateNov 8, 2019

Analyst Consensus

Rating—

Target (Mean)10.00 USD

Target Range10.00 USD – 10.00 USD

# Analysts2

Ownership

Shares Out.186.03M

Float185.23M

Insiders0.43%

Institutions29.22%

Short Interest

Short Ratio9.0d

Short % Float30.81%

Short % Out.30.68%

Shares Short57.07M

Short (prev mo.)56.64M

Technical

SMA 505.582 (+62.0%)

SMA 2003.463 (+161.2%)

Beta2.24

S&P 52W Chg27.70%

Avg Vol (30d)8.46M

Avg Vol (10d)13.37M

Technical Indicators

RSI (14)72.7

MACD1.0082

MACD Signal0.7859

MACD Hist.+0.2223

BB Upper9.908 USD

BB Middle6.762 USD

BB Lower3.617 USD

BB Width93.04%

ATR (14)0.7483 USD

Vol Ratio (20d)2.08x